![]() ![]() The Pfizer-BioNTech vaccine (brand name: Comirnaty) was granted full Food and Drug Administration (FDA) approval in August 2021 for people ages 16 and older. We mapped out a comparison of the most prominent COVID-19 vaccines. In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC).Īs the SARS-CoV-2 virus mutates and new variants continue to emerge, it’s important to keep up with how well the vaccines are performing, but it’s also a daunting task, given the flood of information (and misinformation) coming at us from so many directions. ![]() ![]() The good news is that vaccines are still expected to be effective at preventing severe disease, hospitalization, and death from COVID-19. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for Disease Control & Prevention (CDC), World Health Organization (WHO), and your state and local government.ĬOVID-19 is now in its fourth year, and the Omicron variant and its subvariants are still driving infections in cases in the United States. Information in this article was accurate at the time of original publication. Adults ages 18 years and older who received one or two J&J COVID-19 vaccine doses are recommended to receive one bivalent mRNA dose (Moderna or Pfizer-BioNTech) at least two months after completion of the previous dose. The CDC says that people ages 18 years and older who received one dose of the J&J vaccine should be considered to have received a single-dose J&J primary series. Note: The Johnson & Johnson (Janssen) COVID-19 vaccine is no longer available in the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |